Dr. Keyan Salari: New Study at American Urological Association 2022
Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study "Im...
Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study "Im...
Cory Rice, Medical Director for Biote's training clinic and research facility discusses longevity precision medicine and bioidentical hormone replacemen...
Chris Round, President of EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. Learn more on Health Professional Radio.
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...
James Mish, CEO of 22nd Century Group, a leading agricultural biotechnology company, talks about the company’s commitment and mission to improving hum...
Nelson Ambrogio, Senior Vice President and General Manager of Oncology at Bayer Pharmaceuticals, US., discusses his Boston Marathon run in memory of his...
Michelle Niedziela, PhD, Behavioral Neuroscience Expert and VP of Research and Innovation at HCD Research discusses a first-of-its-kind study for Jiffy ...
Nicole Andrews, Co-Founder, STAAR Ovarian Cancer Foundation which specifically exists to fund life-saving research for women with low-grade serous...
Dan Cua, PhD, Vice President, IL-23 Pathway Leader, Janssen Research & Development, LLC discusses new data showing that TREMFYA binds to both inflammato...
Vivek Lal, CEO and Founder of ResBiotic, discusses the first-of-its-kind supplement that can target the gut-lung axis with clinically validated probioti...